| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.09 | 0.8 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |